Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Sutro Biopharma, Inc. (STRO)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sutro Biopharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Sutro Biopharma, Inc. since 2005.
The reporting company's ticker symbol is STRO. The reporting company's CIK number is 1382101.
The total value of stock buying since 2005 is $9,999,990.
The total value of stock sales since 2005 is $43,018.
The total value of stock option exercises since 2005 is $10,232.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-27||Hallam Trevor (Chief Science Officer)||Sale||975||10.51||10,250|
|2019-12-26||Hallam Trevor (Chief Science Officer)||Sale||975||11.08||10,802|
|2019-11-26||Hallam Trevor (Chief Science Officer)||Sale||975||10.68||10,410|
|2019-10-28||Hallam Trevor (Chief Science Officer)||Sale||975||9.98||9,726|
|2019-09-26||Shabbir Anik (Chief Technical Ops. Officer)||Option Ex||8,608||.00||0|
|2019-09-26||Molina Arturo Md (Chief Medical Officer)||Option Ex||8,608||.00||0|
|2019-09-26||Hallam Trevor (Chief Science Officer)||Option Ex||17,906||.00||0|
|2019-09-26||Newell William J (CEO)||Option Ex||25,252||.00||0|
|2019-09-26||Albini Edward C (CFO and Secretary)||Option Ex||7,174||.00||0|
|2019-09-26||Fitzpatrick Linda A (Chief People & Comm. Officer)||Option Ex||7,575||.00||0|
|2019-09-06||Petree Daniel H (Director)||Option Ex||826||5.09||4,204|
|2019-08-29||Fitzpatrick Linda A (Chief People & Comm. Officer)||Option Ex||826||5.09||4,204|
|2018-10-01||Petree Daniel H (Director)||Sale||122||15.00||1,830|
|2018-10-01||Petree Daniel H (Director)||Option Ex||314||5.81||1,824|
|2018-10-01||Merck Sharp & Dohme Corp. (10% Owner)||Buy||666,666||15.00||9,999,990|
Insider trading activities including stock purchases, stock sales, and option exercises of STRO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sutro Biopharma, Inc. (symbol STRO, CIK number 1382101) see the Securities and Exchange Commission (SEC) website.